폐경 여성의 유산소 능력이 심혈관계 위험인자에 미치는 영향
Effects of Aerobic Capacity on Cardiovascular Risk Factors in Postmenopausal Women
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The purpose of this study was to compare risk factors of cardiovascular disease (CVD) to menopause and premenopausal women, and to examine the effects of aerobic capacity on CVD risk factors. The subjects were 106 middle-aged women under 40~60 years old and classified as postmenopausal women (53.1±3.1 years, n=49) and premenopausal women (45.5±3.7 years, n=57) in a questionnaire. Body composition, aerobic capacity (VO2max) and CVD risk factors (blood pressure, blood lipid, glucose) were measured as measurement variables. The correlation coefficient (r) was calculated by Pearson's product correlation. As a result, menopause women were significantly higher in body mass index, body fat, %body fat, SBP, DBP, TC, LDL-C and glucose than women before menopause (p<.05). VO2max was significantly higher for premenopausal women (24.9±5.0 mL/kg/min) than for menopause women (23.0±4.0 mL/kg/min) (p<.05). In addition, there were significant correlations between VO2max, body mass index (r= -.330), %body fat (r= -.451) and glucose (r= -.264) (p<.05). In conclusion, body composition, blood pressure, blood lipid and glucose are the major CVD risk factors affected by menopause, and CVD prevention is needed before menopause due to correlation with aerobic capacity.
Abstract
The purpose of this study was to compare risk factors of cardiovascular disease (CVD) to menopause and premenopausal women, and to examine the effects of aerobic capacity on CVD risk factors. The subjects were 106 middle-aged women under 40~60 years old and classified as postmenopausal women (53.1±3.1 years, n=49) and premenopausal women (45.5±3.7 years, n=57) in a questionnaire. Body composition, aerobic capacity (VO2max) and CVD risk factors (blood pressure, blood lipid, glucose) were measured as measurement variables. The correlation coefficient (r) was calculated by Pearson's product correlation. As a result, menopause women were significantly higher in body mass index, body fat, %body fat, SBP, DBP, TC, LDL-C and glucose than women before menopause (p<.05). VO2max was significantly higher for premenopausal women (24.9±5.0 mL/kg/min) than for menopause women (23.0±4.0 mL/kg/min) (p<.05). In addition, there were significant correlations between VO2max, body mass index (r= -.330), %body fat (r= -.451) and glucose (r= -.264) (p<.05). In conclusion, body composition, blood pressure, blood lipid and glucose are the major CVD risk factors affected by menopause, and CVD prevention is needed before menopause due to correlation with aerobic capacity.
참고문헌 (32)
- 건강보험통계: 중증질환 산정특례적용 연령 별 성별 진료 현황, "통계청", ~ (2019)
- Abdulnour, J., "Relationship between the percentage of predicted cardiorespiratory fitness and cardiovascular disease risk factors in premenopausal women : a MONET s tudy", Climacteric, 13(4), pp.347~354 (2010)
- ACSM, "ACSM's Guidelines for exercise testing and prescription", pp.2010, Wolters Kluwer Health
- Appiah, D., "Is surgical menopause associated with future levels of cardiovascular risk factor independent of antecedent levels", American Journal of Epidemiology, 182, pp.991~999 (2015)
- Batrinos, M. L., "Premenopause : The Endocrinology of Reproductive Decline", Hormonos, 12(3), pp.334~349 (2013)
- Carr, M. C., "The emergence of the metabolic syndrome with menopause", The Journal of Clinical Endocrinology & Metabolism, 88, pp.2404~2411 (2003)
- Casiglia, E., "Lack of influence of menopause on blood pressure and cardiovascular risk profile : a 16‐year longitudinal study concerning a cohort of 568women", Journal of Hypertension, 14, pp.729~736 (1996)
- Cooke, P. S., "Role of estrogens in adipocyte development and function", Experimental Biology and Medicine, 229(11), pp.1127~1135 (2004)
- de Kat, A. C., "Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study", BMC Medicine, 15, pp.2~ (2017)
- Do, K. A., "Longitudinal study of risk factors for coronary heart disease across the menopausal transition", American Journal of Epidemiology, 151, pp.584~593 (2000)
- Friedewald, W. T., "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clinical Chemistry, 18, pp.499~502 (1972)
- Haddock, B. L., "Cardiorespiratory fitness and cardiovascular disease risk factors in postmenopausal women", Medicine and Science in Sports and Exercise, 30(6), pp.893~898 (1998)
- Harlow, S. D., "STRAW+10Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop+10:Addressing the unfinished agenda of staging reproductive aging", The Journal of Clinical Endocrinology & Metabolism, 97, pp.1159~1168 (2012)
- Hawkins, S. A., "Rate and mechanism of maximal oxygen consumption decline with aging : implications for exercise training", Sports Medicine, 33(12), pp.877~888 (2003)
- Hollenberg, M., "Longitudinal changes in aerobic capacity : implications for concepts of aging", The Journals of Gerontology Series A Biological Sciences and Medical Sciences, 61, pp.851~858 (2006)
- Karvonen-Gutierrez, C., "Association of mid-life changes in body size, body composition and obesity status with the menopausal transition", Healthcare, 4, pp.E42~ (2016)
- Lynch, N. A., "Comparison of VO2max and disease risk factors between perimenopausal and postmenopausal women", Menopause, 9(6), pp.456~462 (2002)
- Mercuro, G., "Impairment of physical exercise capacity in healthy postmenopausal women", American Heart Journal, 151(4), pp.923~927 (2006)
- Messier, V., "Menopause and sarcopenia : a potential role for sex hormones", Maturitas, 68, pp.331~336 (2011)
- Murias, J. M., "Mechanisms for increases in VO2max with endurance training in older and young women", Medicine and Science in Sports and Exercise, 42(10), pp.1891~1898 (2010)
- Nyberg, M., "Biomarkers of vascular function in premenopausal and recent postmenopausal women of s imilar age : effect of exercise training", AJP Regulatory Integrative and Comparative Physiology, 306, pp.R510~R517 (2014)
- Pansini, F., "Oxidative stress, body fat composition, and endocrine status in pre-and postmenopausal women", Menopause, 15, pp.112~118 (2008)
- Poehlman, E. T., "Changes in energy balance and body composition at menopause : a controlled longitudinal study", Annals of Internal Medicine, 123, pp.673~675 (1995)
- Portaluppi, F., "Relative influence of menopausal status, age, and body mass index on blood pressure", Hypertension, 29, pp.976~979 (1997)
- Preis, S. R., "Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005", Circulation, 119(13), pp.1728~1735 (2009)
- Samar, R. EI. Khoudary, "HDL and the Menopause", Curr Opin Lipidol, 28(4), pp.328~336 (2017)
- Staessen, J. A., "Conventional and ambulatory blood pressure and menopause in a prospective population study", The Journal of Human Hypertension, 11, pp.507~514 (1997)
- Stevenson, J. C., "Influence of age and menopause on serum lipids and lipoproteins in healthy women", Atherosclerosis, 98(1), pp.83~90 (1993)
- Teede, H. J., "Obesity, metabolic complications and the menopause : an opportunity for prevention", Climacteric, 13, pp.203~209 (2010)
- Toth, M. J., "Effect of menopausal status on body composition and abdominal fat distribution", International Journal of Obesity and Related Metabolic Disorders, 24(2), pp.226~231 (2000)
- Wu, S. I., "The impact of years since menopause on the development of impaired glucose tolerance", Journal of Clinical Epidemiology, 54(2), pp.117~120 (2001)
- Zanchetti, A., "Menopause-related blood pressure increase and its relationship to age and body mass index : the SIMONA epidemiological study", Journal of Hypertension, 23, pp.2269~2276 (2005)